Asset Details
Do you wish to reserve the book?
Artificial antigen-presenting cells: the booster for the obtaining of functional adoptive cells
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Artificial antigen-presenting cells: the booster for the obtaining of functional adoptive cells
Do you wish to request the book?
Artificial antigen-presenting cells: the booster for the obtaining of functional adoptive cells
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Artificial antigen-presenting cells: the booster for the obtaining of functional adoptive cells
2024
Overview
Adoptive cell therapy (ACT) achieves substantial efficacy in the treatment of hematological malignancies and solid tumours, while enormous endeavors have been made to reduce relapse and extend the remission duration after ACT. For the genetically engineered T cells, their functionality and long-term anti-tumour potential depend on the specificity of the T cell receptor (TCR) or chimeric antigen receptor (CAR). In addition, the therapeutic benefit is directly to sufficient activation and proliferation of engineered T cells. Artificial antigen-presenting cells (aAPCs), as powerful boosters for ACT, have been applied to provide sustained stimulation of the cognate antigen and facilitate the expansion of sufficient T cells for infusion. In this review, we summarize the aAPCs used to generate effector cells for ACT and underline the mechanism by which aAPCs enhance the functionality of the effector cells. The manuscript includes investigations ranging from basic research to clinical trials, which we hope will highlight the importance of aAPCs and provide guidance for novel strategies to improve the effectiveness of ACT.
Publisher
Springer International Publishing,Springer Nature B.V
Subject
/ Antigen-Presenting Cells - immunology
/ Antigens
/ Biomedical and Life Sciences
/ Humans
/ Immunotherapy, Adoptive - methods
/ Receptors, Antigen, T-Cell - immunology
/ Receptors, Antigen, T-Cell - metabolism
/ Receptors, Chimeric Antigen - genetics
/ Receptors, Chimeric Antigen - immunology
/ Receptors, Chimeric Antigen - metabolism
/ relapse
/ Review
